Results 21 to 30 of about 9,289 (208)

Developing a prediction model for all‐cause mortality risk among patients with type 2 diabetes mellitus in Shanghai, China 中国上海地区建立的2型糖尿病患者全因死亡风险预测模型

open access: yesJournal of Diabetes, Volume 15, Issue 1, Page 27-35, January 2023., 2023
Highlights This study constructed the first 5‐year all‐cause mortality risk prediction model for patients with type 2 diabetes mellitus in south China. This well‐performing model, using highly accessible predictors collected in routine clinical settings, provides a powerful tool for clinicians to identify high‐risk diabetic patients.
Jiying Qi   +10 more
wiley   +1 more source

Implications of fetal premature atrial contractions: systematic review

open access: yesUltrasound in Obstetrics &Gynecology, Volume 60, Issue 6, Page 721-730, December 2022., 2022
ABSTRACT Objective Fetal heart‐rate irregularities occur in 1–2% of pregnancies and are usually caused by premature atrial contractions (PAC). Although PAC are considered benign, they may be associated with cardiac defects and tachyarrhythmia. We aimed to determine the incidence of congenital heart defects (CHDs) and complications in fetuses with PAC ...
B. B. Bet   +6 more
wiley   +1 more source

Health utilities in Chinese patients with coronary heart disease and impaired glucose tolerance (ACE): A longitudinal analysis of a randomized, double‐blind, placebo‐controlled trial 中国冠心病合并糖耐量异常患者的健康相关生活质量:一项随机、双盲、安慰剂对照试验的纵向分析

open access: yesJournal of Diabetes, Volume 14, Issue 7, Page 455-464, July 2022., 2022
Highlights The Acarbose Cardiovascular Evaluation (ACE) trial assessed the effects of acarbose in patients with coronary heart disease (CHD) and impaired glucose tolerance (IGT) in China. Acarbose treatment did not impact on health‐related quality of life in ACE trial participants with CHD and IGT. Myocardial infarction (MI), stroke, heart failure, and
José Leal   +4 more
wiley   +1 more source

A Systematic Review and Meta‐Analysis of High‐Frequency Prescription of Zhigancao Decoction Combined with Conventional Western Medicine in the Treatment of Chronic Heart Failure

open access: yesEvidence-Based Complementary and Alternative Medicine, Volume 2021, Issue 1, 2021., 2021
Background. Chronic heart failure is the main critical illness and cause of death in the later stages of cardiovascular disease, and it is one of the two major challenges in the field of cardiovascular research. The clinical application of traditional Chinese medicine in the prevention and treatment of chronic heart failure has been relatively common ...
Qianyan Wu   +6 more
wiley   +1 more source

Efficacy and Safety Combined with Conventional and Western Medicine Treatments on Coronary Heart Disease Complicated with Heart Failure:a Systematic Review [PDF]

open access: yes, 2022
BackgroundAnti-atherosclerotic and anti-heart failure therapies are the key to the treatment of coronary heart disease (CHD) , a common cardiovascular disease.
WANG Tianyuan, WANG Yanbo, FENG Shuo, HU Jing, ZHANG Huina, WANG Hong, LI Bo
core   +1 more source

Reliability and Validity of the Chinese Version of the Partners in Health Scale in Patients with Chronic Heart Failure [PDF]

open access: yes, 2022
BackgroundChronic heart failure (CHF) is a common cardiovascular disease. Improving the self-management ability of CHF patients will contribute to quality of life improvement and reduction of rehospitalization and mortality rates. The Partners in Health (
WANG Xiaonan, JIANG Ying, KANG Xiaofeng, JI Shiming, ZHANG Jian
core   +1 more source

Characteristics and Prognosis of Herat Failure with Improved Ejection Fraction [PDF]

open access: yes, 2022
BackgroundLeft ventricular ejection fraction (LVEF) is often used to classify heart failure (HF) . Some HF patients were observed to have improved ejection fraction after treatment, thus giving rise to the concept of HF with improved EF (HFimpEF ...
SU Kangkang, WANG Yan, WANG Lili, CHEN Shuxia, GU Jian
core   +1 more source

高敏肌钙蛋白T与慢性心力衰竭的相关性及对急性心肌梗死的鉴别价值

open access: greenZhongguo shiyan zhenduanxue, 2019
目的探讨高敏肌钙蛋白T与慢性心力衰竭的相关性及对急性心肌梗死的鉴别价值。方法检测2015年9月至2018年8月收治的50例慢性心力衰竭患者、50例急性心肌梗死患者和50例体检者的高敏肌钙蛋白T水平,进行比较。根据心功能分级将心衰组分为A组(≤Ⅱ级)、B组(>Ⅱ级),比较两组高敏肌钙蛋白T水平。根据高敏肌钙蛋白T水平将心衰组分为高水平组、正常组,比较两组随访6个月的再入院率。结果心梗组高敏肌钙蛋白T水平高于心衰组和对照组,B组该指标水平高于A组,高水平组随访6个月的再入院率高于正常组,差异有统计学意义 ...
任美英, 刘莹, 郭晓杰
doaj   +1 more source

Heart Failure with Mid-range Ejection Fraction——a Comprehension of the Disease [PDF]

open access: yes, 2022
Heart failure is the final main battlefield of various cardiovascular diseases with huge harm, which can cause all kinds of arrhythmias and even sudden cardiac death. The 2016 ESC guidelines formally define heart failure with mid-range ejection fraction (
RUAN Zheng, HUANG Jianyu, JIANG Wencai, CHEN Meixiang, QIN Changyu, XU Lin
core   +1 more source

G protein‐coupled receptor kinase‐2: A potential biomarker for early diabetic cardiomyopathy G蛋白偶联受体激酶2:早期糖尿病心肌病的潜在生物标记物

open access: yesJournal of Diabetes, Volume 12, Issue 3, Page 247-258, March 2020., 2020
Highlights The GRK2 level elevated not only in the myocardium of diabetic mice with early stage of diabetic cardiomyopathy but also in the peripheral blood mononuclear cells of type 2 diabetic patients with the early stage of diabetic cardiomyopathy. The study findings suggested that the GRK2 was a potential biomarker for early diabetic cardiomyopathy.
Shuiqing Lai   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy